Similar articles for PMID: 22669764

Year	Number of Results
1998	1
1999	2
2000	1
2001	4
2002	5
2003	6
2004	3
2005	6
2006	6
2007	4
2008	7
2009	7
2010	12
2011	7
2012	9
2013	7
2014	5
2015	10
2016	9
2017	5
2018	2
2019	1
2020	3
2021	1
2022	2
2023	1
2024	0

1

Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.

Held JM, Britton DJ, Scott GK, Lee EL, Schilling B, Baldwin MA, Gibson BW, Benz CC. Held JM, et al. Mol Cancer Res. 2012 Aug;10(8):1120-32. doi: 10.1158/1541-7786.MCR-12-0099. Epub 2012 Jun 5. Mol Cancer Res. 2012. PMID: 22669764 Free PMC article.

2

Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells.

Węsierska-Gądek J, Gritsch D, Zulehner N, Komina O, Maurer M. Węsierska-Gądek J, et al. J Cell Biochem. 2011 Mar;112(3):761-72. doi: 10.1002/jcb.23004. J Cell Biochem. 2011. PMID: 21328450

3

Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.

Lipfert L, Fisher JE, Wei N, Scafonas A, Su Q, Yudkovitz J, Chen F, Warrier S, Birzin ET, Kim S, Chen HY, Tan Q, Schmidt A, Dininno F, Rohrer SP, Hammond ML, Rodan GA, Freedman LP, Reszka AA. Lipfert L, et al. Mol Endocrinol. 2006 Mar;20(3):516-33. doi: 10.1210/me.2005-0190. Epub 2005 Oct 13. Mol Endocrinol. 2006. PMID: 16223974

4

Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.

Chen D, Washbrook E, Sarwar N, Bates GJ, Pace PE, Thirunuvakkarasu V, Taylor J, Epstein RJ, Fuller-Pace FV, Egly JM, Coombes RC, Ali S. Chen D, et al. Oncogene. 2002 Jul 25;21(32):4921-31. doi: 10.1038/sj.onc.1205420. Oncogene. 2002. PMID: 12118371

5

Interactions between MAP kinase and oestrogen receptor in human breast cancer.

McGlynn LM, Tovey S, Bartlett JM, Doughty J, Cooke TG, Edwards J. McGlynn LM, et al. Eur J Cancer. 2013 Apr;49(6):1176-86. doi: 10.1016/j.ejca.2012.11.020. Epub 2012 Dec 19. Eur J Cancer. 2013. PMID: 23265704

6

Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.

Harrod A, Fulton J, Nguyen VTM, Periyasamy M, Ramos-Garcia L, Lai CF, Metodieva G, de Giorgio A, Williams RL, Santos DB, Gomez PJ, Lin ML, Metodiev MV, Stebbing J, Castellano L, Magnani L, Coombes RC, Buluwela L, Ali S. Harrod A, et al. Oncogene. 2017 Apr 20;36(16):2286-2296. doi: 10.1038/onc.2016.382. Epub 2016 Oct 17. Oncogene. 2017. PMID: 27748765 Free PMC article.

7

Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells.

Stender JD, Nwachukwu JC, Kastrati I, Kim Y, Strid T, Yakir M, Srinivasan S, Nowak J, Izard T, Rangarajan ES, Carlson KE, Katzenellenbogen JA, Yao XQ, Grant BJ, Leong HS, Lin CY, Frasor J, Nettles KW, Glass CK. Stender JD, et al. Mol Cell. 2017 Mar 16;65(6):1122-1135.e5. doi: 10.1016/j.molcel.2017.02.008. Mol Cell. 2017. PMID: 28306507 Free PMC article.

8

Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.

Al-Dhaheri MH, Rowan BG. Al-Dhaheri MH, et al. Mol Endocrinol. 2007 Feb;21(2):439-56. doi: 10.1210/me.2006-0059. Epub 2006 Oct 26. Mol Endocrinol. 2007. PMID: 17068199

9

Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells.

Węsierska-Gądek J, Gritsch D, Zulehner N, Komina O, Maurer M. Węsierska-Gądek J, et al. J Cell Biochem. 2011 Apr;112(4):1103-17. doi: 10.1002/jcb.23024. J Cell Biochem. 2011. PMID: 21308739

10

Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.

Kuske B, Naughton C, Moore K, Macleod KG, Miller WR, Clarke R, Langdon SP, Cameron DA. Kuske B, et al. Endocr Relat Cancer. 2006 Dec;13(4):1121-33. doi: 10.1677/erc.1.01257. Endocr Relat Cancer. 2006. PMID: 17158758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year